韩国肺癌协会临床实践指南制定:径向探头支气管内超声诊断肺癌的推荐意见——一项更新的Meta分析
本更新的Meta分析系统检索MEDLINE和EMBASE(2013年1月至2022年12月),纳入41项研究共13,133个周围型肺病灶,评估径向探头支气管内超声引导经支气管活检的诊断率。汇总诊断率为0.72(95%CI 0.70~0.75),研究间异质性显著(I²=86.4%);RP-EBUS表现(病灶内、邻近、不可见)间诊断率差异有统计学意义。总体并发症率6.8%(出血4.5%,气胸1.4%),用于制定韩国肺癌协会指南推荐。
要点
- RP-EBUS引导经支气管活检诊断周围型肺病灶的汇总诊断率为0.72(95%CI 0.70~0.75)。
- RP-EBUS表现病灶内 vs 邻近的比值比为1.45(95%CI 1.23~1.72),病灶内 vs 不可见为4.20(95%CI 1.89~9.32),邻近 vs 不可见为2.59(95%CI 1.32~5.01)。
- 总体并发症率6.8%,其中出血4.5%、气胸1.4%。
核心结论
- RP-EBUS引导经支气管活检是诊断周围型肺病灶的准确工具,安全性良好,尤其对RP-EBUS表现为病灶内或CT支气管征阳性的病灶。
研究设计与样本
- 更新的Meta分析,系统检索MEDLINE和EMBASE(2013年1月至2022年12月),纳入41项研究共13,133个周围型肺病灶,使用R软件进行Meta分析,诊断率按成功诊断数除以总病灶数计算,并做亚组分析。
诊断标准与关键数值
- RP-EBUS引导经支气管活检诊断周围型肺病灶的汇总诊断率为0.72(95%CI 0.70~0.75)。
- RP-EBUS表现病灶内 vs 邻近的比值比为1.45(95%CI 1.23~1.72),病灶内 vs 不可见为4.20(95%CI 1.89~9.32),邻近 vs 不可见为2.59(95%CI 1.32~5.01)。
- 诊断率在病灶大小、组织学诊断、CT支气管征、病灶性质及距肺门位置方面差异有统计学意义。
- 总体并发症率为6.8%,其中出血4.5%、气胸1.4%。
临床应用与阅片要点
- 作者指出RP-EBUS引导经支气管活检是诊断周围型肺病灶的准确工具,安全性良好,尤其适用于RP-EBUS表现为病灶内或CT支气管征阳性的病灶。
局限性
- 研究间异质性显著(χ²=292.38,p<0.01,I²=86.4%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Radial probe endobronchial ultrasound (RP-EBUS) accurately locates peripheral lung lesions (PLLs) during transbronchial biopsy (TBB). We performed an updated meta-analysis of the diagnostic yield of TBB for PLLs using RP-EBUS to generate recommendations for the development of the Korean Association of Lung Cancer guidelines.
MATERIALS AND METHODS: We systematically searched MEDLINE and EMBASE (from January 2013 to December 2022), and performed a meta-analysis using R software. The diagnostic yield was evaluated by dividing the number of successful diagnoses by the total lesion number. Subgroup analysis was performed to identify related factors.
RESULTS: Forty-one studies with a total of 13,133 PLLs were included. The pooled diagnostic yield of RP-EBUS was 0.72 (95% confidence interval [CI], 0.70 to 0.75). Significant heterogeneity was observed among studies (χ2=292.38, p < 0.01, I2=86.4%). In a subgroup analysis, there was a significant difference in diagnostic yield based on RP-EBUS findings (within, adjacent to, invisible), with a risk ratio of 1.45 (95% CI, 1.23 to 1.72) between within and adjacent to, 4.20 (95% CI, 1.89 to 9.32) between within and invisible, and 2.59 (95% CI, 1.32 to 5.01) between adjacent to and invisible. There was a significant difference in diagnostic yield based on lesion size, histologic diagnosis, computed tomography (CT) bronchus sign, lesion character, and location from the hilum. The overall complication rate of TBB with RP-EBUS was 6.8% (bleeding, 4.5%; pneumothorax, 1.4%).
CONCLUSION: Our study showed that TBB with RP-EBUS is an accurate diagnostic tool for PLLs with good safety profiles, especially for PLLs with within orientation on RP-EBUS or positive CT bronchus sign.
引用
- Kim SH, Chung HS, Kim J, et al. Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis. Cancer Res Treat. 2023. PMID: 38037321. doi:10.4143/crt.2023.749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。